Michael Pfaller: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Characterization of an Ochratoxin-A-Dedifferentiated and Cloned Renal Epithelial Cell Line

Michael Gekle, Birgit Gaßner, Ruth Freudinger, Sigrid Mildenberger, Stefan Silbernagl, Walter Pfaller, Herbert Schramek

Journal:

Toxicology and Applied Pharmacology

Year:

1998

Language:

english

File:

PDF, 3.98 MB

english, 1998

52

Transcriptomic alterations induced by Ochratoxin A in rat and human renal proximal tubular in vitro models and comparison to a rat in vivo model

Paul Jennings, Christina Weiland, Alice Limonciel, Katarzyna M. Bloch, Robert Radford, Lydia Aschauer, Tara McMorrow, Anja Wilmes, Walter Pfaller, Hans J. Ahr, Craig Slattery, Edward A. Lock, Michael

Journal:

Archives of Toxicology

Year:

2012

Language:

english

File:

PDF, 282 KB

english, 2012

53

Coagulase-negative staphylococci: Why and when to do what

Frank Koontz, Michael Pfaller

Journal:

Clinical Microbiology Newsletter

Year:

1989

Language:

english

File:

PDF, 446 KB

english, 1989

54

Use of plasmid profiles and restriction endonuclease analysis of plasmid DNA as epidemiologic and diagnostic tools in the clinical microbiology laboratory

Michael A. Pfaller, Richard J. Hollis

Journal:

Clinical Microbiology Newsletter

Year:

1989

Language:

english

File:

PDF, 556 KB

english, 1989

55

The yeast connection: is Candida linked to breastfeeding associated pain?

Janet I. Andrews, Diedre K. Fleener, Shawn A. Messer, Wendy F. Hansen, Michael A. Pfaller, Daniel J. Diekema

Journal:

American Journal of Obstetrics and Gynecology

Year:

2007

Language:

english

File:

PDF, 103 KB

english, 2007

56

Saubollized

Gary V. Doern, Franklin P. Koontz, Ronald N. Jones, Michael A. Pfaller

Journal:

Clinical Microbiology Newsletter

Year:

1998

Language:

english

File:

PDF, 221 KB

english, 1998

57

Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere

Janet I. Andrews, Daniel J. Diekema, Stephen K. Hunter, Paul R. Rhomberg, Michael A. Pfaller, Ronald N. Jones, Gary V. Doern

Journal:

American Journal of Obstetrics and Gynecology

Year:

2000

Language:

english

File:

PDF, 150 KB

english, 2000

58

In Vitro Antifungal Susceptibility Testing

Holly L. Hoffman, Michael A. Pfaller

Journal:

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Year:

2001

Language:

english

File:

PDF, 71 KB

english, 2001

59

Epidemiology of Invasive Mycoses in North America

Pfaller, Michael A., Diekema, Daniel J.

Journal:

Critical Reviews in Microbiology

Year:

2010

Language:

english

File:

PDF, 1.70 MB

english, 2010

60

Carapace epibionts of loggerhead turtles (Caretta caretta) nesting at Canaveral National Seashore, Florida

Pfaller, Joseph B., Frick, Michael G., Reich, Kimberly J., Williams, Kristina L., Bjorndal, Karen A.

Journal:

Journal of Natural History

Year:

2008

Language:

english

File:

PDF, 211 KB

english, 2008

61

Infection control: The premier quality assessment program in United States hospitals

Richard P. Wenzel, Michael A. Pfaller

Journal:

The American Journal of Medicine

Year:

1991

Language:

english

File:

PDF, 707 KB

english, 1991

62

Reemergence of epidemic methicillin-resistant Staphylococcus aureus in a general hospital associated with changing Staphylococcal strains

Calvin C. Linnemann Jr., Peggy Moore, Joseph L. Staneck, Michael A. Pfaller

Journal:

The American Journal of Medicine

Year:

1991

Language:

english

File:

PDF, 1.20 MB

english, 1991

63

Methicillin-resistant Staphylococcus aureus: Implications for the 1990s and effective control measures

Richard P. Wenzel, Mary D. Nettleman, Ronald N. Jones, Michael A. Pfaller

Journal:

The American Journal of Medicine

Year:

1991

Language:

english

File:

PDF, 1.20 MB

english, 1991

64

Assigning responsibility: using feedback to achieve sustained control of methicillin-resistant Staphylococcus aureus

Mary D. Nettleman, Antoni Trilla, Mary Fredrickson, Michael Pfaller

Journal:

The American Journal of Medicine

Year:

1991

Language:

english

File:

PDF, 2.08 MB

english, 1991

65

Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis

Michael A. Pfaller, S.A. Messer, Richard J. Hollis

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

1995

Language:

english

File:

PDF, 660 KB

english, 1995

66

Evidence of nosocomial spread of Candida albicans causing bloodstream infection in a neonatal intensive care unit

David R. Reagan, Michael A. Pfaller, Richard J. Hollis, Richard P. Wenzel

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

1995

Language:

english

File:

PDF, 512 KB

english, 1995

67

Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the united states II. Study of the intra- and interlaboratory dissemination of extended-spectrum β-lactamase-producing Enterobacteriaceae

Helio S. Sader, Michael A. Pfaller, Ronald N. Jones

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

1994

Language:

english

File:

PDF, 529 KB

english, 1994

68

Vitek GPS card susceptibility testing accuracy using direct inoculation from Bactec 9240 blood culture bottles

Wanita J. Howard, Barry J. Buschelman, Martha J. Bale, Michael A. Pfaller, Frank P. Koontz, Ronald N. Jones

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

1996

Language:

english

File:

PDF, 450 KB

english, 1996

69

Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients

Francesco Barchiesi, Richard J. Hollis, Shawn A. Messer, Giorgio Scalise, Michael G. Rinaldi, Michael A. Pfaller

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

1995

Language:

english

File:

PDF, 1.14 MB

english, 1995

70

Invasive Mycoses: Evolving Challenges and Opportunities in Antifungal Therapy (Multimedia Activity)

John R. Perfect, Michael A. Pfaller, Luis Ostrosky-Zeichner, Dimitrios P. Kontoyiannis

Journal:

The American Journal of Medicine

Year:

2011

Language:

english

File:

PDF, 266 KB

english, 2011

71

Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment

Michael A. Pfaller

Journal:

The American Journal of Medicine

Year:

2012

Language:

english

File:

PDF, 433 KB

english, 2012

72

Integrin-Linked Kinase Controls Microtubule Dynamics Required for Plasma Membrane Targeting of Caveolae

Sara A. Wickström, Anika Lange, Michael W. Hess, Julien Polleux, Joachim P. Spatz, Marcus Krüger, Kristian Pfaller, Armin Lambacher, Wilhelm Bloch, Matthias Mann, Lukas A. Huber, Reinhard Fässler

Journal:

Developmental Cell

Year:

2010

Language:

english

File:

PDF, 2.66 MB

english, 2010

73

Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?

Erika J Ernst, Daniel J Diekema, Bonnie J BootsMiller, Thomas Vaughn, Jon W Yankey, Stephen D Flach, Marcia M Ward, Carrie L.J Franciscus, Elise Acosta, Michael A Pfaller, Bradley N Doebbeling

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2004

Language:

english

File:

PDF, 159 KB

english, 2004

74

Clade-related amphotericin B resistance among South African Candida albicans isolates

Elaine Blignaut, Julitha Molepo, Claude Pujol, David R. Soll, Michael A. Pfaller

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2005

Language:

english

File:

PDF, 90 KB

english, 2005

75

Review of in vitro activity of sertaconazole nitrate in the treatment of superficial fungal infections

Michael A. Pfaller, Deanna A. Sutton

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2006

Language:

english

File:

PDF, 179 KB

english, 2006

76

Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998–2004)

Michael A. Pfaller, Helio S. Sader, Thomas R. Fritsche, Ronald N. Jones

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2006

Language:

english

File:

PDF, 119 KB

english, 2006

77

Flavophospholipol use in animals: Positive implications for antimicrobial resistance based on its microbiologic properties

Michael A. Pfaller

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2006

Language:

english

File:

PDF, 153 KB

english, 2006

78

Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis

Gregory T. Siwek, Michael A. Pfaller, Philip M. Polgreen, Sandra Cobb, Peter Hoth, Margarida Magalheas-Silverman, Daniel J. Diekema

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2006

Language:

english

File:

PDF, 89 KB

english, 2006

79

Oral β-lactams in the treatment of acute bacterial rhinosinusitis

James A. Hadley, Michael A. Pfaller

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2007

Language:

english

File:

PDF, 173 KB

english, 2007

80

Evaluation of the in vitro activity of daptomycin against 19 615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002–2005)

Michael A. Pfaller, Helio S. Sader, Ronald N. Jones

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2007

Language:

english

File:

PDF, 124 KB

english, 2007

81

Oral β-lactams in the treatment of acute otitis media

Stan L. Block, Gary V. Doern, Michael A. Pfaller

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2007

Language:

english

File:

PDF, 216 KB

english, 2007

82

Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998–2004) [Diagnostic Microbiology and Infectious Disease 56, 63–68, 2006]

Michael A. Pfaller, Helio S. Sader, Thomas R. Fritsche, Ronald N. Jones

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2007

Language:

english

File:

PDF, 67 KB

english, 2007

83

Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections

David L. Horn, Jay A. Fishman, William J. Steinbach, Elias J. Anaissie, Kieren A. Marr, Ali J. Olyaei, Michael A. Pfaller, Mark A. Weiss, Karen M. Webster, Dionissios Neofytos

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2007

Language:

english

File:

PDF, 284 KB

english, 2007

84

Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection

Michael J. Klevay, Erika J. Ernst, Jesse L. Hollanbaugh, Joshua G. Miller, Michael A. Pfaller, Daniel J. Diekema

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2008

Language:

english

File:

PDF, 183 KB

english, 2008

85

Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis

Riina Rautemaa, Malcolm Richardson, Michael A. Pfaller, Jaakko Perheentupa, Harri Saxén

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2008

Language:

english

File:

PDF, 172 KB

english, 2008

86

A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.

Daniel J. Diekema, Shawn A. Messer, Richard J. Hollis, Linda Boyken, Shailesh Tendolkar, Jennifer Kroeger, Ronald N. Jones, Michael A. Pfaller

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2009

Language:

english

File:

PDF, 194 KB

english, 2009

87

Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection

Michael J. Klevay, David L. Horn, Dionissios Neofytos, Michael A. Pfaller, Daniel J. Diekema

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2009

Language:

english

File:

PDF, 146 KB

english, 2009

88

Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program

Michael A. Pfaller, Linda Boyken, Richard J. Hollis, Jennifer Kroeger, Shawn A. Messer, Shailesh Tendolkar, Daniel J. Diekema

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2009

Language:

english

File:

PDF, 181 KB

english, 2009

89

Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods

Michael A. Pfaller, Linda Boyken, Richard J. Hollis, Jennifer Kroeger, Shawn A. Messer, Shailesh Tendolkar, Daniel J. Diekema

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2010

Language:

english

File:

PDF, 422 KB

english, 2010

90

Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program

Michael A. Pfaller, Daniel J. Diekema, David L. Gibbs, Vance A. Newell, Richard Barton, Hu Bijie, Jacques Bille, Shan-Chwen Chang, Maria da Luz Martins, Adriano Duse, Danuta Dzierzanowska, David Ellis

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2010

Language:

english

File:

PDF, 198 KB

english, 2010

91

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009)

Michael A. Pfaller, Mariana Castanheira, Shawn A. Messer, Gary J. Moet, Ronald N. Jones

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2010

Language:

english

File:

PDF, 162 KB

english, 2010

92

Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)

Michael A. Pfaller, Mariana Castanheira, Shawn A. Messer, Gary J. Moet, Ronald N. Jones

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2011

Language:

english

File:

PDF, 160 KB

english, 2011

93

Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria

Michael A. Pfaller, David Andes, Maiken C. Arendrup, Daniel J. Diekema, Ana Espinel-Ingroff, Barbara D. Alexander, Steven D. Brown, Vishnu Chaturvedi, Cynthia L. Fowler, Mahmoud A. Ghannoum, Elizabeth

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2011

Language:

english

File:

PDF, 286 KB

english, 2011

94

In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method

Michael A. Pfaller, Katsura Hata, Ronald N. Jones, Shawn A. Messer, Gary J. Moet, Mariana Castanheira

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2011

Language:

english

File:

PDF, 165 KB

english, 2011

95

Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method

Michael A. Pfaller, Mariana Castanheira, Daniel J. Diekema, Shawn A. Messer, Ronald N. Jones

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2011

Language:

english

File:

PDF, 223 KB

english, 2011

96

The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012

Nkechi Azie, Dionissios Neofytos, Michael Pfaller, Herwig-Ulf Meier-Kriesche, Shun-Ping Quan, David Horn

Journal:

Diagnostic Microbiology and Infectious Disease

Year:

2012

Language:

english

File:

PDF, 344 KB

english, 2012

97

Evidence for recombination in Candida glabrata

Andrew R. Dodgson, Claude Pujol, Michael A. Pfaller, David W. Denning, David R. Soll

Journal:

Fungal Genetics and Biology

Year:

2005

Language:

english

File:

PDF, 789 KB

english, 2005

98

Analysis of ALS5 and ALS6 allelic variability in a geographically diverse collection of Candida albicans isolates

Xiaomin Zhao, Soon-Hwan Oh, Robert Jajko, Daniel J. Diekema, Michael A. Pfaller, Claude Pujol, David R. Soll, Lois L. Hoyer

Journal:

Fungal Genetics and Biology

Year:

2007

Language:

english

File:

PDF, 573 KB

english, 2007

99

Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis

Ali Abdul Lattif, Pranab K. Mukherjee, Jyotsna Chandra, Kim Swindell, Shawn R. Lockhart, Daniel J. Diekema, Michael A. Pfaller, Mahmoud A. Ghannoum

Journal:

International Journal of Medical Microbiology

Year:

2010

Language:

english

File:

PDF, 1.40 MB

english, 2010

100

Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment

Michael A Pfaller, Anton F Ehrhardt, Ronald N Jones

Journal:

The American Journal of Medicine

Year:

2001

Language:

english

File:

PDF, 140 KB

english, 2001